Citigroup Maintains Buy on CME Gr, Raises Price Target to $250
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Christopher Allen maintains a Buy rating on CME Group and raises the price target from $240 to $250.
October 03, 2024 | 5:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Christopher Allen has reiterated a Buy rating for CME Group and increased the price target from $240 to $250, indicating a positive outlook.
The increase in price target from $240 to $250 by Citigroup suggests a positive outlook for CME Group, likely leading to a short-term increase in stock price as investors react to the analyst's confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100